Catalyst Wire Dossier Catalyst Wire Dossier

Gladem

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gladem, covering 2014-09-04 to 2014-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study to Assess a 6-months Treatment With Gladem

See pricing